New Long-Acting HIV shots aim to keep virus undetectable
NCT ID NCT07402044
First seen Feb 12, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study looks at how well a long-acting injectable combination of two drugs, cabotegravir and lenacapavir, controls HIV. About 50 adults with HIV who are already on or starting this treatment will be followed for a year. The main goal is to see if the virus stays suppressed (below 50 copies/mL) and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CABOTEGRAVIR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Archet 1Hospital
Nice, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Bichat Claude Bernard Hospital
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Franco-British Hospital (Fbh)
Levallois-Perret, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hotel Dieu Hospital
Nantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hotel Dieu Hospital
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Necker Hospital
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pellegrin Hospital
Bordeaux, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pitié Salpêtrière Hospital
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Raymond poincaré Hospital
Garches, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Saint André Hospital
Bordeaux, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Saint Antoine Hospital
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tourcoing Hospital
Tourcoing, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Victor Dupuy Hospital
Argenteuil, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.